Parkinson's disease

Clin Neuropharmacol. 1999 Jul-Aug;22(4):184-91.
No abstract available

Publication types

  • Review

MeSH terms

  • Amantadine / therapeutic use
  • Antidepressive Agents / adverse effects
  • Antihypertensive Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Antipsychotic Agents / adverse effects
  • Carbidopa / blood
  • Carbidopa / therapeutic use
  • Dopamine / biosynthesis
  • Dopamine Agonists / therapeutic use*
  • Drug Interactions
  • Humans
  • Levodopa / blood
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy*
  • Parkinson Disease, Secondary / chemically induced

Substances

  • Antidepressive Agents
  • Antihypertensive Agents
  • Antiparkinson Agents
  • Antipsychotic Agents
  • Dopamine Agonists
  • Levodopa
  • Amantadine
  • Carbidopa
  • Dopamine